Cargando…
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets
Platelet transfusion is a common clinical approach to providing platelets to patients suffering from thrombocytopenia or other ailments that require an additional platelet source. However, a stable supply of platelet products is challenged by aging societies, pandemics, and other factors. Many group...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792917/ https://www.ncbi.nlm.nih.gov/pubmed/36574167 http://dx.doi.org/10.1007/s12185-022-03512-8 |